Cargando…

Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale

We describe a 55-year-old woman with lung cancer complicated by bone metastases. Treatment with denosumab (120 mg monthly) was interrupted after 9 doses because of concern for potential osteonecrosis of the jaw during upcoming dental work. Fifteen months after receiving the last dose of denosumab, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tyan, Alexander, Patel, Sandip Pravin, Block, Shanna, Hughes, Tudor, McCowen, Karen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543257/ https://www.ncbi.nlm.nih.gov/pubmed/31193884 http://dx.doi.org/10.1016/j.mayocpiqo.2019.02.003

Ejemplares similares

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab
por: Anastasilakis, Athanasios D., et al.
Publicado: (2023)

Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases
por: Dupont, Jolan, et al.
Publicado: (2022)

Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
por: Anastasilakis, Athanasios D., et al.
Publicado: (2021)

Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
por: Kim, Albert S., et al.
Publicado: (2022)

Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation
por: Anastasilakis, Athanasios D., et al.
Publicado: (2020)

Rebound-Associated Vertebral Fractures Two Months After a Missed Dose of Denosumab
por: Caseja, Ahl Jeffrey, et al.
Publicado: (2021)

Symptomatic Rebound Hypercalcemia After Denosumab Discontinuation in a Pediatric Patient With Cherubism
por: Marpuri, Ian, et al.
Publicado: (2021)

THU448 Multiple Non-traumatic Vertebral Fractures After Discontinuation Of Denosumab
por: Riahi, Shayan, et al.
Publicado: (2023)

Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
por: Fu, Qiang, et al.
Publicado: (2023)

Bone Health and Denosumab Discontinuation in Oncology Populations
por: Cheung, Yee-Ming Melody, et al.
Publicado: (2022)

Failure of Oral Risedronate Therapy to Prevent Spontaneous Vertebral Fracture in a Patient Ceasing Denosumab: A Cautionary Case
por: Davidoff, Dahlia F, et al.
Publicado: (2020)

Pseudothrombocytopenia--a cautionary tale.
por: Kettle, P., et al.
Publicado: (1991)

Japan: A Cautionary Tale
por: Tran, Vinh
Publicado: (2010)

Cullen, a Cautionary Tale
por: Dyde, Sean
Publicado: (2015)

MERS – A cautionary tale
por: Häfner, Sophia, et al.
Publicado: (2015)

Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
por: Kim, Bu Kyung, et al.
Publicado: (2021)

The Role of Bisphosphonates Prior to Denosumab Treatment on Rebound Fractures: A Mini Review
por: Inojosa, Arthur Costa, et al.
Publicado: (2022)

The clinical development of NRTIs — cautionary tales
por: Cooper, D
Publicado: (2010)

A cautionary tale of virus and disease
por: Weiss, Robin A
Publicado: (2010)

Supercell refinement: a cautionary tale
por: Lovelace, Jeffrey, et al.
Publicado: (2019)

Floss abrasion: a cautionary tale
por: Cooper, J., et al.
Publicado: (2020)

A Cautionary Tale of Triple Therapy
por: Shahandeh, Negeen, et al.
Publicado: (2021)

Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation
por: Gonzalez-Rodriguez, Elena, et al.
Publicado: (2018)

Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report
por: Kashii, Masafumi, et al.
Publicado: (2020)

Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses
por: Cosman, Felicia, et al.
Publicado: (2022)

Cautionary Tales: Ethics and Case Studies in Science
por: Herreid, Clyde Freeman
Publicado: (2014)

Florivory and pollinator visitation: a cautionary tale
por: Tsuji, Kaoru, et al.
Publicado: (2016)

Post-obstructive Diuresis: A Cautionary Tale
por: Singh, Amardeep, et al.
Publicado: (2019)

FURIN and placental syncytialisation: a cautionary tale
por: Morosin, Saije K., et al.
Publicado: (2021)

A Cautionary Tale: Unveiling Valentino’s Syndrome
por: Mahajan, Parag S, et al.
Publicado: (2022)

Mosaic embryo transfer: a cautionary tale
por: Franasiak, Jason M.
Publicado: (2022)

Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
por: Burckhardt, Peter, et al.
Publicado: (2021)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

History of the measurement of glucose in urine: a cautionary tale.
por: Davison, J M, et al.
Publicado: (1974)

Case report: PET/CT, a cautionary tale
por: Wang, Jayson, et al.
Publicado: (2007)

H5N1: A Cautionary Tale
por: Ehrlich, Susan A.
Publicado: (2014)

An unusual case of severe haematemesis: a cautionary tale
por: Gregory, IS, et al.
Publicado: (2011)

Mechanical transduction by ion channels: A cautionary tale
por: Sachs, Frederick
Publicado: (2015)

Decreased Identification of Vesicoureteral Reflux: A Cautionary Tale
por: Qureshi, Aslam Hyder, et al.
Publicado: (2017)

Metastatic Squamous Cell Carcinoma: A Cautionary Tale
por: Shreve, Colby, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mqer4q1pfe2tcha71p8l3uuhts